Next Article in Journal
Dural MALT Lymphoma with Disseminated Disease
Previous Article in Journal
Autonomic Dysfunction in Hodgkin and Non-Hodgkin Lymphoma. A Paraneoplastic Syndrome?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 2
Issue 1
10.4081/hr.2010.e9
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A

by
Ren'an Chen
,
Li Liu
and
Yinmin Liang
*
Department of Haematology, Tang du Hospital, Fourth Military Medical University, Xi’an 710038, China
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2010, 2(1), e9; https://doi.org/10.4081/hr.2010.e9
Submission received: 29 September 2010 / Revised: 20 November 2010 / Accepted: 23 November 2010 / Published: 30 November 2010

Abstract

A 25-year-old man was diagnosised subcutaneous panniculitis-like T-cell lymphoma (SPTCL) through biopsy of a nodule from the anterior chest. After the treatment with prednisone 90 mg 3 weeks and tapered off in 1 month, the disease released, but relapsed together with symptions of hemophagocytic syndrome eight months after the termination of prednisone. CHOEP recipe was given but with unsatisfactory result until cyclosporine was prescribed. Cyclosporine was removed 6 months later. There is no evidence of clinical relapse 1 year later. This case suggest that cyclosporine could be a selectable treatment even in relapsed SPTCL.
Keywords: relapsed; subcutaneous panniculitislike T-cell lymphoma; cyclosporin A relapsed; subcutaneous panniculitislike T-cell lymphoma; cyclosporin A

Share and Cite

MDPI and ACS Style

Chen, R.; Liu, L.; Liang, Y. Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A. Hematol. Rep. 2010, 2, e9. https://doi.org/10.4081/hr.2010.e9

AMA Style

Chen R, Liu L, Liang Y. Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A. Hematology Reports. 2010; 2(1):e9. https://doi.org/10.4081/hr.2010.e9

Chicago/Turabian Style

Chen, Ren'an, Li Liu, and Yinmin Liang. 2010. "Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A" Hematology Reports 2, no. 1: e9. https://doi.org/10.4081/hr.2010.e9

APA Style

Chen, R., Liu, L., & Liang, Y. (2010). Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A. Hematology Reports, 2(1), e9. https://doi.org/10.4081/hr.2010.e9

Article Metrics

Back to TopTop